174 related articles for article (PubMed ID: 38612906)
21. Proteomics of liquid biopsies: Depicting RCC infiltration into the renal vein by MS analysis of urine and plasma.
Chinello C; Stella M; Piga I; Smith AJ; Bovo G; Varallo M; Ivanova M; Denti V; Grasso M; Grasso A; Del Puppo M; Zaravinos A; Magni F
J Proteomics; 2019 Jan; 191():29-37. PubMed ID: 29689304
[TBL] [Abstract][Full Text] [Related]
22. Defining candidate mRNA and protein EV biomarkers to discriminate ccRCC and pRCC from non-malignant renal cells in vitro.
Zieren RC; Dong L; Clark DJ; Kuczler MD; Horie K; Moreno LF; Lih TM; Schnaubelt M; Vermeulen L; Zhang H; de Reijke TM; Pienta KJ; Amend SR
Med Oncol; 2021 Jul; 38(9):105. PubMed ID: 34331598
[TBL] [Abstract][Full Text] [Related]
23. Glycosphingolipid structural analysis and glycosphingolipidomics.
Levery SB
Methods Enzymol; 2005; 405():300-69. PubMed ID: 16413319
[TBL] [Abstract][Full Text] [Related]
24. iTRAQ-based quantitative proteomic analysis reveals potential early diagnostic markers of clear-cell Renal cell carcinoma.
Zhang L; Jiang H; Xu G; Chu N; Xu N; Wen H; Gu B; Liu J; Mao S; Na R; Jing Y; Ding Q; Zhang Y; Wang L
Biosci Trends; 2016 Jul; 10(3):210-9. PubMed ID: 27319973
[TBL] [Abstract][Full Text] [Related]
25. Value of global metabolomics in association with diagnosis and clinicopathological factors of renal cell carcinoma.
Sato T; Kawasaki Y; Maekawa M; Takasaki S; Saigusa D; Ota H; Shimada S; Yamashita S; Mitsuzuka K; Yamaguchi H; Ito A; Kinoshita K; Koshiba S; Mano N; Arai Y
Int J Cancer; 2019 Jul; 145(2):484-493. PubMed ID: 30628065
[TBL] [Abstract][Full Text] [Related]
26. Prognostic urinary miRNAs for the assessment of small renal masses.
Di Meo A; Brown MD; Finelli A; Jewett MAS; Diamandis EP; Yousef GM
Clin Biochem; 2020 Jan; 75():15-22. PubMed ID: 31672647
[TBL] [Abstract][Full Text] [Related]
27. Discovery and validation of urinary biomarkers for detection of renal cell carcinoma.
Frantzi M; Metzger J; Banks RE; Husi H; Klein J; Dakna M; Mullen W; Cartledge JJ; Schanstra JP; Brand K; Kuczyk MA; Mischak H; Vlahou A; Theodorescu D; Merseburger AS
J Proteomics; 2014 Feb; 98():44-58. PubMed ID: 24374379
[TBL] [Abstract][Full Text] [Related]
28. Label-free quantitative proteomic analysis reveals potential biomarkers and pathways in renal cell carcinoma.
Zhao Z; Wu F; Ding S; Sun L; Liu Z; Ding K; Lu J
Tumour Biol; 2015 Feb; 36(2):939-51. PubMed ID: 25315187
[TBL] [Abstract][Full Text] [Related]
29. UPLC-MS based urine untargeted metabolomic analyses to differentiate bladder cancer from renal cell carcinoma.
Wang Z; Liu X; Liu X; Sun H; Guo Z; Zheng G; Zhang Y; Sun W
BMC Cancer; 2019 Dec; 19(1):1195. PubMed ID: 31805976
[TBL] [Abstract][Full Text] [Related]
30. Comprehensive profiling of ceramides in human serum by liquid chromatography coupled to tandem mass spectrometry combining data independent/dependent acquisition modes.
Luque-Córdoba D; Calderón-Santiago M; Rangel-Zúñiga OA; Camargo A; López-Miranda J; Priego-Capote F
Anal Chim Acta; 2024 Jan; 1287():342115. PubMed ID: 38182388
[TBL] [Abstract][Full Text] [Related]
31. Characterization of Glycosphingolipids and Their Diverse Lipid Forms through Two-Stage Matching of LC-MS/MS Spectra.
Bailey LS; Huang F; Gao T; Zhao J; Basso KB; Guo Z
Anal Chem; 2021 Feb; 93(6):3154-3162. PubMed ID: 33534538
[TBL] [Abstract][Full Text] [Related]
32. Differentiation and Quantification of Diastereomeric Pairs of Glycosphingolipids Using Gas-Phase Ion Chemistry.
Chao HC; McLuckey SA
Anal Chem; 2020 Oct; 92(19):13387-13395. PubMed ID: 32883073
[TBL] [Abstract][Full Text] [Related]
33. Analysis of urinary sphingolipids using liquid chromatography-tandem mass spectrometry in diabetic nephropathy.
Morita Y; Kurano M; Sakai E; Nishikawa T; Nishikawa M; Sawabe M; Aoki J; Yatomi Y
J Diabetes Investig; 2020 Mar; 11(2):441-449. PubMed ID: 31580528
[TBL] [Abstract][Full Text] [Related]
34. Mass Spectrometry of Neutral Glycosphingolipids.
Suzuki A; Silsirivanit A; Watanabe T; Matsuda J; Inamori KI; Inokuchi JI
Methods Mol Biol; 2023; 2613():127-144. PubMed ID: 36587076
[TBL] [Abstract][Full Text] [Related]
35. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
36. GC-MS metabolomics-based approach for the identification of a potential VOC-biomarker panel in the urine of renal cell carcinoma patients.
Monteiro M; Moreira N; Pinto J; Pires-Luís AS; Henrique R; Jerónimo C; Bastos ML; Gil AM; Carvalho M; Guedes de Pinho P
J Cell Mol Med; 2017 Sep; 21(9):2092-2105. PubMed ID: 28378454
[TBL] [Abstract][Full Text] [Related]
37. Chemoenzymatic synthesis of the oligosaccharide moiety of the tumor-associated antigen disialosyl globopentaosylceramide.
't Hart IME; Li T; Wolfert MA; Wang S; Moremen KW; Boons GJ
Org Biomol Chem; 2019 Aug; 17(31):7304-7308. PubMed ID: 31339142
[TBL] [Abstract][Full Text] [Related]
38. Immunoaffinity enrichment and liquid chromatography-selected reaction monitoring mass spectrometry for quantitation of carbonic anhydrase 12 in cultured renal carcinoma cells.
Rafalko A; Iliopoulos O; Fusaro VA; Hancock W; Hincapie M
Anal Chem; 2010 Nov; 82(21):8998-9005. PubMed ID: 20936840
[TBL] [Abstract][Full Text] [Related]
39. Urinary RKIP/p-RKIP is a potential diagnostic and prognostic marker of clear cell renal cell carcinoma.
Papale M; Vocino G; Lucarelli G; Rutigliano M; Gigante M; Rocchetti MT; Pesce F; Sanguedolce F; Bufo P; Battaglia M; Stallone G; Grandaliano G; Carrieri G; Gesualdo L; Ranieri E
Oncotarget; 2017 Jun; 8(25):40412-40424. PubMed ID: 28418894
[TBL] [Abstract][Full Text] [Related]
40. 14-3-3 protein beta/alpha as a urinary biomarker for renal cell carcinoma: proteomic analysis of cyst fluid.
Minamida S; Iwamura M; Kodera Y; Kawashima Y; Tabata K; Matsumoto K; Fujita T; Satoh T; Maeda T; Baba S
Anal Bioanal Chem; 2011 Jul; 401(1):245-52. PubMed ID: 21553213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
